Hyperpolarized 129Xenon Gas
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Bastiaan Driehuys
Overview
Hyperpolarized 129Xenon Gas is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
Hyperpolarized 129Xenon Gas clinical trials
Explore related
Medical disclaimer. This page summarizes research about Hyperpolarized 129Xenon Gas for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.